Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS)

Clinical trial NCT02428686 · COMPLETED

Trial details

NCT number: NCT02428686
Sponsor: Groupe Francophone des Myelodysplasies
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2010-06-01
Primary completion: 2014-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.